274 related articles for article (PubMed ID: 16260420)
1. Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma.
Barzon L; Masi G; Fincati K; Pacenti M; Pezzi V; Altavilla G; Fallo F; Palù G
Eur J Endocrinol; 2005 Nov; 153(5):629-36. PubMed ID: 16260420
[TBL] [Abstract][Full Text] [Related]
2. Metastatic adrenocortical carcinoma presenting simultaneously with Cushing's and Conn's syndromes: a case report.
Beom SH; Lee KW; Yang Y; Choi Y; Song KH; Kim YJ; Kim JH; Bang SM; Chung JH; Lee JS
Jpn J Clin Oncol; 2011 Nov; 41(11):1287-91. PubMed ID: 21980052
[TBL] [Abstract][Full Text] [Related]
3. Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.
Uchida T; Nishimoto K; Fukumura Y; Asahina M; Goto H; Kawano Y; Shimizu F; Tsujimura A; Seki T; Mukai K; Kabe Y; Suematsu M; Gomez-Sanchez CE; Yao T; Horie S; Watada H
Endocr Pathol; 2017 Mar; 28(1):27-35. PubMed ID: 27430645
[TBL] [Abstract][Full Text] [Related]
4. Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma. Case report and review of the literature.
Weingärtner K; Gerharz EW; Bittinger A; Rosai J; Leppek R; Riedmiller H
Urol Int; 1995; 55(4):232-5. PubMed ID: 8588274
[TBL] [Abstract][Full Text] [Related]
5. A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy.
Ushiyama T; Suzuki K; Kageyama S; Fujita K; Oki Y; Yoshimi T
J Urol; 1997 Jun; 157(6):2239. PubMed ID: 9146626
[No Abstract] [Full Text] [Related]
6. Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Kurtulmus N; Yarman S; Azizlerli H; Kapran Y
Horm Res; 2004; 62(2):67-70. PubMed ID: 15218335
[TBL] [Abstract][Full Text] [Related]
7. Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
Pusantisampan T; Sangkhathat S; Kayasut K; Kanngurn S; Jaruratanasirikul S; Chotsampancharoen T; Kritsaneepaiboon S
Pediatr Dev Pathol; 2010; 13(3):238-42. PubMed ID: 19863445
[TBL] [Abstract][Full Text] [Related]
8. [Isolated primary hyperaldosteronism caused by adrenocortical carcinoma].
Parajó A; Fírvida JL; Otero E; García M; Montero M
Arch Esp Urol; 2000 Dec; 53(10):931-4. PubMed ID: 11213398
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of glutathione-peroxidase (GSH-PO) in human adrenal gland--studies on adrenocortical adenomas associated with primary aldosteronism and Cushing's syndrome.
Murakoshi M; Osamura RY; Yoshimura S; Watanabe K
Tokai J Exp Clin Med; 1995 Jul; 20(2):89-97. PubMed ID: 8797265
[TBL] [Abstract][Full Text] [Related]
10. Re: A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy.
Nelson JB; Kavoussi LR; Walther MM
J Urol; 1998 Apr; 159(4):1310. PubMed ID: 9507868
[No Abstract] [Full Text] [Related]
11. Development of ipsilateral adrenocortical carcinoma sixteen years after resection of an adrenal tumour causing Cushing's syndrome.
Tan HS; Thai AC; Nga ME; Mukherjee JJ
Ann Acad Med Singap; 2005 Apr; 34(3):271-4. PubMed ID: 15902349
[TBL] [Abstract][Full Text] [Related]
12. Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma.
Baert D; Nobels F; Van Crombrugge P
Acta Clin Belg; 1995; 50(5):310-3. PubMed ID: 8533534
[TBL] [Abstract][Full Text] [Related]
13. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
14. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
16. [Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism].
Farge D; Pagny JY; Chatellier G; Plouin PF; Corvol P
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():83-7. PubMed ID: 3142435
[TBL] [Abstract][Full Text] [Related]
17. Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients.
Guilhaume B; Sanson ML; Billaud L; Bertagna X; Laudat MH; Luton JP
Eur J Med; 1992 May; 1(2):83-9. PubMed ID: 1342378
[TBL] [Abstract][Full Text] [Related]
18. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
19. [A case report of double adrenocortical adenomata due to Cushing's syndrome and primary aldosteronism].
Takaki R; Kano K; Sato S; Miyamura S; Hama H
Horumon To Rinsho; 1980 Jul; 28(7):777-83. PubMed ID: 7460329
[No Abstract] [Full Text] [Related]
20. Pigmented adrenocortical carcinoma: case report and review.
Geller JL; Azer PC; Weiss LM; Mertens RB
Endocr Pathol; 2006; 17(3):297-304. PubMed ID: 17308367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
